Contract development and manufacturing organization (CDMO) Abzena has announced the formation of a strategic partnership with ...

Overview: The global Artificial Intelligence (AI) in drug discovery market is projected to grow at a rate of 25-30% over the next five years. Key factors driving this growth include the increasing ...

In the rapidly evolving world of biotechnology and pharmaceuticals, innovation is the key to staying ahead. One of the most ...

TandemAI announced it has secured a $22 million Series A extension to further develop its drug discovery platform, which ...

In recent years, the conversation around artificial intelligence (AI) in healthcare has intensified, especially in the realm of drug discovery. Reshma Kewalramani, the CEO of Vertex Pharmaceuticals, ...

AI drives decision inputs: In 2025, both big pharma and small pharma use advanced predictive modeling, digital twins, and AI-powered analytics throughout R&D and regulatory processes. This reduces ...

RNA plays a vital role in how our genes are expressed and how diseases develop. Yet, because RNA molecules constantly change ...

Received FDA IND clearance to evaluate CDI-988 as both norovirus preventive and treatmentExpects to initiate CDI-988 Phase 1b ...

Have you ever wondered how scientists test new medicines before they reach people? The process must be safe, accurate, and ...

BenchSci, which sells AI-powered software for biopharmaceutical research and development (R&D), says it has struck a ...

With the rapid advancements in computer technology and bioinformatics, the prediction of protein-ligand binding sites has ...